Core Viewpoint - Lin Qingxuan is accelerating its IPO process after receiving the CSRC filing notice, with updated IPO application materials now available on the Hong Kong Stock Exchange website [1] Company Overview - Lin Qingxuan, a pioneer in the "oil-based skincare" sector, has focused on anti-wrinkle and firming skincare products, becoming a leading brand in cell-level anti-wrinkle essence oils [1] - The company's flagship product, the Camellia Oil Anti-Wrinkle Repair Essence Oil, has ranked first in retail sales among all facial essence oil products in China for 11 consecutive years since 2014 [1] Financial Performance - The company's total revenue has shown consistent growth over the past three years, with a compound annual growth rate (CAGR) of 32.3%, increasing from RMB 691 million in 2022 to RMB 1.21 billion in 2024 [1] - In the first half of this year, the company achieved a net profit of RMB 182 million, with a gross margin of 82.4%, and the gross margin for the essence oil category reached 86.2% [1] Product Sales Performance - The Lin Qingxuan Black Gold Time Peptide Anti-Wrinkle Brightening Cream is projected to generate RMB 61.5 million in revenue for 2024, with RMB 50 million already achieved in the first half of 2025, making it one of the best-selling products [2] - The Lin Qingxuan High SPF Sunscreen has rapidly developed since its launch in 2024, generating RMB 36.3 million in its first year and increasing to RMB 42.1 million in the first half of this year, indicating strong market recognition [2] Industry Growth Potential - The market for high-end anti-wrinkle and firming skincare products is expected to grow from RMB 59.4 billion in 2024 to RMB 155.5 billion by 2029, with a CAGR of 21.2% [2] - The overall high-end skincare market in China is projected to reach RMB 218.5 billion by 2029, with a CAGR of 13.8% from 2024 to 2029 [2] - As a leading brand in the high-end domestic skincare industry, Lin Qingxuan is well-positioned to benefit from strong R&D capabilities and existing leading products [2]

Core Viewpoint - Lin Qingxuan is the only domestic high-end skincare brand among the top 15 in China, focusing on anti-wrinkle and firming products, with a strong emphasis on natural ingredients like camellia oil [1][7]. Company Overview - Founded in 2003, Lin Qingxuan specializes in high-end skincare products, particularly those based on camellia flower ingredients [3]. - The flagship product, Camellia Essence Oil, launched in 2014, has sold over 30 million bottles and has been the top-selling facial essence oil in China for 11 consecutive years [5]. Product Development - Lin Qingxuan has developed a range of patented ingredients and products, including various serums, creams, and masks, totaling 188 SKUs as of December 31, 2024 [6]. - The company has introduced several successful products, such as the Camellia Black Gold Anti-Wrinkle Cream, generating significant revenue in its first year [6]. Market Position - As of 2024, Lin Qingxuan ranks first among domestic high-end skincare brands in China and is the only domestic brand in the top 15 overall [7]. - The brand leads the market in high-end anti-wrinkle and firming products among domestic brands [7]. Customer Engagement - Lin Qingxuan has over 4.3 million active customers, with an average annual repurchase rate of approximately 34.6%, surpassing the industry average [8]. Distribution Channels - The company operates 506 stores, primarily in shopping malls, with a significant portion being direct-operated stores, ensuring consistent customer experience [10]. - Online sales have seen rapid growth, with a compound annual growth rate of 51.2% from 2022 to 2024 [10]. Financial Performance - Lin Qingxuan's revenue has grown from 691 million yuan in 2022 to 1.21 billion yuan in 2024, with a compound annual growth rate of 32.5% [12]. - The company achieved profitability in 2023, with adjusted net profits exceeding 200 million yuan in 2024 [13]. Future Plans - Lin Qingxuan aims to expand into Southeast Asian markets as part of its globalization strategy [11]. - The company plans to use IPO proceeds to enhance brand value, sales networks, production capabilities, and technological development [14]. Industry Outlook - The high-end skincare market in China is projected to grow from 74.9 billion yuan in 2019 to 114.4 billion yuan in 2024, with anti-wrinkle products expected to see a compound annual growth rate of 21.2% [14].